As of 2026-04-03, the Relative Valuation of Mithra Pharmaceuticals SA (MITRA.BR) is (33.72) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 0.22 EUR, the upside of Mithra Pharmaceuticals SA based on Relative Valuation is -15713.2%.
The range of the Relative Valuation is (30.86) - (37.69) EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 7.5x - 11.3x | 9.2x |
| Forward P/E multiples | 9.2x - 12.0x | 10.9x |
| Fair Price | (30.86) - (37.69) | (33.72) |
| Upside | -14388.2% - -17549.6% | -15713.2% |
| Date | P/E |